| Jenburkt Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524731 |
NSE Symbol : - |
P/E(TTM) : 13.73 |
|
ISIN Demat : INE354A01013 |
Div & Yield% : 1.78 |
EPS(TTM) : 84.61 |
|
Book Value(₹) : 446.47 |
Market Cap(₹Cr) : 512.85 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 168.74 | 151.69 | 141.97 | 136.75 | 123.98 |
| Other Income | 10.30 | 6.72 | 4.67 | 5.12 | 4.95 |
| Stock Adjustments | 4.85 | 0.12 | 0.39 | -1.34 | 2.28 |
| Total Income | 183.89 | 158.53 | 147.03 | 140.53 | 131.21 |
| EXPENDITURE : | |||||
| Raw Materials | 37.17 | 29.77 | 30.80 | 31.67 | 33.72 |
| Power and Fuel Cost | 0.76 | 0.71 | 0.75 | 0.76 | 0.61 |
| Other Manufacturing Expenses | 4.95 | 4.30 | 3.58 | 4.28 | 3.85 |
| Selling and Administration Expenses | 36.44 | 30.27 | 31.04 | 29.03 | 24.32 |
| Miscellaneous Expenses | 4.60 | 0.83 | 0.58 | 0.50 | 0.01 |
| Employee Benefit Expenses | 49.88 | 45.54 | 42.49 | 38.81 | 36.49 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 50.09 | 47.11 | 37.79 | 35.49 | 32.20 |
| Interest | 0.46 | 0.45 | 0.27 | 0.37 | 0.43 |
| Gross Profit | 49.63 | 46.66 | 37.52 | 35.12 | 31.77 |
| Depreciation | 3.11 | 2.73 | 2.34 | 2.26 | 1.90 |
| Profit Before Tax | 46.52 | 43.93 | 35.18 | 32.86 | 29.87 |
| Current Tax | 12.64 | 12.08 | 9.72 | 8.48 | 7.28 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.86 | -0.21 | -0.52 | -0.23 | 0.30 |
| Reported Net Profit | 34.74 | 32.06 | 25.98 | 24.61 | 22.30 |
| Extraordinary Items | -2.61 | 1.02 | 0.04 | 0.00 | 0.14 |
| Adjusted Net Profit | 37.35 | 31.04 | 25.94 | 24.61 | 22.16 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | -14.34 | 0.00 |
| Profit/Loss Balance carried down | 162.34 | 134.12 | 113.11 | 108.53 | 90.91 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 6.91 | 3.84 | 4.96 | 5.69 | 4.68 |
| P & L Balance carried down | 190.17 | 162.34 | 134.12 | 113.10 | 108.53 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 207.00 | 180.00 | 153.00 | 144.00 | 120.00 |
| Dividend Per Share(Rs) | 20.70 | 18.00 | 15.30 | 14.40 | 12.00 |
| Earnings Per Share-Unit Curr | 78.71 | 72.65 | 58.86 | 55.76 | 48.58 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 446.47 | 389.23 | 328.42 | 277.32 | 255.77 |
| Book Value(Adj)-Unit Curr | 446.47 | 389.23 | 328.42 | 277.32 | 255.77 |
